The Ecstasy and Agony of Assay Interference Compounds

ACS Infect Dis. 2017 Apr 14;3(4):259-262. doi: 10.1021/acsinfecdis.7b00023. Epub 2017 Feb 28.

Authors

Courtney Aldrich¹, Carolyn Bertozzi², Gunda I Georg³, Laura Kiessling⁴, Craig Lindsley⁵, Dennis Liotta⁶, Kenneth M Merz Jr⁷, Alanna Schepartz⁸, Shaomeng Wang³

Affiliations

¹ ACS Infectious Diseases.
² ACS Central Science.
³ Journal of Medicinal Chemistry.
⁴ ACS Chemical Biology.
⁵ ACS Chemical Neuroscience.
⁶ ACS Medicinal Chemistry Letters.
⁷ Journal of Chemical Information and Modeling.
⁸ Biochemistry.

PMID: 28244723
DOI: 10.1021/acsinfecdis.7b00023

No abstract available

Publication types

Editorial

MeSH terms

Drug Discovery / methods*
Drug Discovery / standards
Drug Evaluation, Preclinical / methods*
Drug Evaluation, Preclinical / standards
Humans